新股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

零售商股

1,052.008

+5.8730.56%

漲家數：3

跌家數：4

平家數：14

市盈率：- -

高：1,052.194

開：1,046.135

低：1,044.280

收：1,046.135

成交量：328.04萬

成交額：98.83萬

市值：88.08億

流通市值：21.81億

資料載入中...

和鉑醫藥：HBM9378/WIN378治療哮喘II期臨床取得陽性中期結果並啓動III期研究

科倫博泰生物：SKB378/WIN378治療哮喘的2期臨床取得陽性結果及3期研究啓動

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK6514/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK6514","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6514\",,,,,undefined,":{"symbol":"BK6514","market":"SI","secType":"PLATE","nameCN":"零售商股","latestPrice":1052.0084,"timestamp":1789117461099,"preClose":1046.1351,"halted":0,"volume":3280400,"delay":0,"changeRate":0.005614,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":5.873291,"latestTime":"09-11 17:16:00 SGT","open":1046.1351,"high":1052.1938,"low":1044.2803,"amount":988277.7,"amplitude":0.007565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789345800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789086600000,1789099200000],[1789102800000,1789118160000]],"pbRate":0.952347,"peRate":17.191395,"turnoverRate":0.000312,"increases":3,"decrements":4,"flats":16,"marketCap":8807540623,"floatMarketCap":2180567737.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6514\",,,,,undefined,":{"symbol":"BK6514","high":1052.1938,"amplitude":0.007565,"preClose":1046.1351,"low":1044.2803,"pbRate":"0.952347","latestPrice":1052.0084,"volume":3280400,"delay":0,"open":1046.1351,"prevYearClose":1110.3745,"prevWeekClose":1049.3406,"prevMonthClose":1013.3159,"prevQuarterClose":1051.4308,"fiveDayClose":1049.3406,"twentyDayClose":1037.0033,"sixtyDayClose":1072.4749,"secType":"PLATE","market":"SI","turnoverRate":0.000312,"peRate":17.191395,"marketCap":8807540623,"floatMarketCap":2180567737.5,"timestamp":1789117461099,"nameCN":"零售商股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6514\",,,,undefined,":{"bkCode":"BK6514","up":3,"down":4,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6514\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665967373","title":"和鉑醫藥：HBM9378/WIN378治療哮喘II期臨床取得陽性中期結果並啓動III期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2665967373","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665967373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:53","pubTimestamp":1788871980,"startTime":"0","endTime":"0","summary":"9月8日，和铂医药-B(02142.HK)合作伙伴Windward Bio AG公布，HBM9378/WIN378用于治疗哮喘的POLARIS-1临床试验II期部分取得阳性的中期结果，POLARIS-1的III期部分亦已启动。 HB ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260908/c679714030.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260908/c679714030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK6008","BK6514","5BI.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665014320","title":"科倫博泰生物：SKB378/WIN378治療哮喘的2期臨床取得陽性結果及3期研究啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665014320","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665014320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":"9月8日，科伦博泰生物(06990.HK)发布公告，公司的合作方Windward Bio AG(Windward Bio)已公布SKB378/WIN378(一款靶向胸腺基质淋巴细胞生成素(TSLP)的全人源超长效单克隆抗体)用于治疗哮喘 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260908/c679711373.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260908/c679711373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["5BI.SI","BK6514","BK6008"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}